Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) therapy is rapidly expanding worldwide, yet this therapy has a serious risk of bleeding. Whether coagulation-activating viral infections such as COVID-19 may have an impact on the risk of bleeding is largely unknown. This study conducted a mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Flinspach, Armin Niklas, Bobyk, Dorothée, Zacharowski, Kai, Neef, Vanessa, Raimann, Florian Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573698/
https://www.ncbi.nlm.nih.gov/pubmed/37835059
http://dx.doi.org/10.3390/jcm12196415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573698/
https://www.ncbi.nlm.nih.gov/pubmed/37835059
http://dx.doi.org/10.3390/jcm12196415

Ejemplares similares